Skip to content

TLSI TRISALUS LIFE SCIENCES INC

Follow

COM (common), issuer CIK 1826667

Filings received so far for Q3 2026: 2 13F filers report a position in TLSI shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Cox Bryan F.officer (Chief of Research)2026-10-05-296 S$4.39Form 4
Marshak Richardofficer (Chief Commercial Officer)2026-10-05-325 S$4.39Form 4
Stevens Jenniferofficer (Chief Regulatory Officer)2026-10-05-316 S$4.39Form 4
Szela Mary Tdirector, officer (CEO and President)2026-10-05-2,693 F$4.38Form 4

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
GAMMA Investing LLC193$832<0.01%new13F-HRTimeline
Farther Finance Advisors, LLC80$345<0.01%+213F-HRTimeline

Events

  • Cox Bryan F. sold 296 TLSI shares on 2026-10-05, Form 4 filed 2026-10-07. 0001628280-26-065326

    Accepted , ingested
  • Marshak Richard sold 325 TLSI shares on 2026-10-05, Form 4 filed 2026-10-07. 0001628280-26-065325

    Accepted , ingested
  • Stevens Jennifer sold 316 TLSI shares on 2026-10-05, Form 4 filed 2026-10-07. 0001628280-26-065324

    Accepted , ingested
  • Szela Mary T disposed of 2,693 TLSI shares on 2026-10-05, Form 4 filed 2026-10-07. 0001628280-26-065323

    Accepted , ingested